British Journal of Pharmacology · 1971 · 179 citations · 11 references
MedicineNeurosciencePharmacologyNeurochemistryNeuropharmacologyPsychopharmacologyAmino Acid NeurochemistryMonoamine NeurochemistryNeurochemical PharmacologySerotonergic PharmacologyAdhd HyperactivityMonoamine Oxidase InhibitionMonoamine Oxidase InhibitorsMonoamine Oxidase InvolvementMonoamine PharmacologyPhysiological AntagonismSerotonin SynthesisTryptophan Metabolism
1. The hyperactivity and hyperpyrexia produced by L-tryptophan in rats treated with a monoamine oxidase inhibitor was inhibited by chlorpromazine.2. Chlorpromazine did not inhibit the increased rate of synthesis of brain 5-hydroxytryptamine (5-HT) produced by tryptophan loading.3. Hyperactivity and hyperpyrexia were also produced by 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) in rats. Pretreatment with a monoamine oxidase inhibitor potentiated the hyperactivity response. Pretreatment of rats with p-chlorophenylalanine did not inhibit hyperactivity produced by 5-MeODMT.4. Chlorpromazine inhibits hyperactivity caused by tryptophan or 5-MeODMT after monoamine oxidase inhibition either by competition with 5-HT or 5-MeODMT, respectively, at receptor sites or by physiological antagonism.
11
The determination of tryptophan in plasma, liver, and urine.
W D Denckla, Henry K. Dewey · PubMed · 1967 · 828 citations
The biosynthesis of 5-hydroxytryptamine in brain
Biochemical Journal · 1967 · 107 citations · Full text